Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00947310 · ClinicalTrials.gov registry record · NA
Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
NCT00947310 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,500 participants.
The verdict
NCT00947310, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
This study will assess the impact of higher rate cutoffs and longer delays than standard programming on inappropriate therapy in primary prevention ICD and CRT-D patients.
Interventions
- DEVICE Standard ICD programming
- DEVICE High rate cutoff
- DEVICE Long delay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00947310
The ClinicalTrials.gov registry entry for NCT00947310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard ICD programming is the first listed.
NCT00947310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00947310 about?
NCT00947310 is a clinical study titled "Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy". This study will assess the impact of higher rate cutoffs and longer delays than standard programming on inappropriate therapy in primary prevention ICD and CRT-D patients.
What is the current status of trial NCT00947310?
This trial is currently completed. It is a NA study. The enrollment target is 1,500 participants. The study started on 2009-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00947310?
The interventions under investigation include: Standard ICD programming (DEVICE), High rate cutoff (DEVICE), Long delay (DEVICE).
Who is sponsoring clinical trial NCT00947310?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.